Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Hideki Yoshikawa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hideki Wakui < Hideki Yoshikawa < Hideko Kozuru  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 12.
Ident.Authors (with country if any)Title
000149 (2009) Jun Hashimoto [Japon] ; Patrick Garnero ; Désirée Van Der Heijde ; Nobuyuki Miyasaka ; Kazuhiko Yamamoto ; Shinichi Kawai ; Tsutomu Takeuchi ; Hideki Yoshikawa ; Norihiro NishimotoA combination of biochemical markers of cartilage and bone turnover, radiographic damage and body mass index to predict the progression of joint destruction in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.
000254 (2010) Jun Hashimoto [Japon] ; Patrick Garnero [France] ; Désirée Van Der Heijde [Pays-Bas] ; Nobuyuki Miyasaka [Japon] ; Kazuhiko Yamamoto [Japon] ; Shinichi Kawai [Japon] ; Tsutomu Takeuchi [Japon] ; Hideki Yoshikawa [Japon] ; Norihiro Nishimoto [Japon]Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study
000387 (2011) Makoto Hirao [Japon] ; Akihide Nampei ; Kenrin Shi ; Hideki Yoshikawa ; Norihiro Nishimoto ; Jun HashimotoDiagnostic features of mild cellulitis phlegmon in patients with rheumatoid arthritis treated with tocilizumab: a report of two cases.
000451 (2012) Makoto Hirao [Japon] ; Naomi Yamasaki ; Hiroki Oze ; Kosuke Ebina ; Akihide Nampei ; Yoshitaka Kawato ; Kenrin Shi ; Hideki Yoshikawa ; Norihiro Nishimoto ; Jun HashimotoSerum level of oxidative stress marker is dramatically low in patients with rheumatoid arthritis treated with tocilizumab.
001179 (2017) Shoichi Kaneshiro [Japon] ; Kosuke Ebina [Japon] ; Makoto Hirao [Japon] ; Hideki Tsuboi [Japon] ; Masataka Nishikawa [Japon] ; Akihide Nampei [Japon] ; Yoshio Nagayama [Japon] ; Koichiro Takahi ; Takaaki Noguchi [Japon] ; Hajime Owaki [Japon] ; Jun Hashimoto [Japon] ; Hideki Yoshikawa [Japon]The efficacy and safety of additional administration of tacrolimus in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab.
001386 (2017) Shunsei Hirohata [Japon] ; Asami Abe [Japon] ; Akira Murasawa [Japon] ; Toshihisa Kanamono ; Tetsuya Tomita [Japon] ; Hideki Yoshikawa [Japon]Differential effects of IL-6 blockade tocilizumab and TNF inhibitors on angiogenesis in synovial tissues from patients with rheumatoid arthritis.
001986 (2018) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Akira Ohnishi [Japon] ; Daijiro Kabata [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Shuzo Yoshida [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Kengo Akashi [Japon] ; Takanori Fujimura [Japon] ; Makoto Hirao [Japon] ; Keiichi Yamamoto [Japon] ; Ayumi Shintani [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug retention and discontinuation reasons between seven biologics in patients with rheumatoid arthritis -The ANSWER cohort study.
001A93 (2019) Kosuke Ebina [Japon] ; Akira Miyama [Japon] ; Hideki Tsuboi [Japon] ; Shoichi Kaneshiro [Japon] ; Masataka Nishikawa [Japon] ; Hajime Owaki [Japon] ; Shigeyoshi Tsuji [Japon] ; Makoto Hirao [Japon] ; Yuki Etani [Japon] ; Atsushi Goshima [Japon] ; Jun Hashimoto [Japon] ; Hideki Yoshikawa [Japon]The add-on effectiveness and safety of iguratimod in patients with rheumatoid arthritis who showed an inadequate response to tocilizumab.
001E96 (2019) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis-the ANSWER cohort study.
001F31 (2019) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Correction to: Drug tolerability and reasons for discontinuation of seven biologics in 4466 treatment courses of rheumatoid arthritis—the ANSWER cohort study
001F35 (2019) Kosuke Ebina [Japon] ; Motomu Hashimoto [Japon] ; Wataru Yamamoto [Japon] ; Toru Hirano [Japon] ; Ryota Hara [Japon] ; Masaki Katayama [Japon] ; Akira Onishi [Japon] ; Koji Nagai [Japon] ; Yonsu Son [Japon] ; Hideki Amuro [Japon] ; Keiichi Yamamoto [Japon] ; Yuichi Maeda [Japon] ; Koichi Murata [Japon] ; Sadao Jinno [Japon] ; Tohru Takeuchi [Japon] ; Makoto Hirao [Japon] ; Atsushi Kumanogoh [Japon] ; Hideki Yoshikawa [Japon]Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis -The ANSWER cohort study-
002240 (2019) Daisuke Tateiwa ; Hideki Yoshikawa ; Takashi KaitoCartilage and Bone Destruction in Arthritis: Pathogenesis and Treatment Strategy: A Literature Review

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Hideki Yoshikawa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Hideki Yoshikawa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Hideki Yoshikawa
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021